382 Lebrikizumab provides clinically meaningful improvements in atopic dermatitis in patients previously treated with dupilumab.
Saved in:
| Title: | 382 Lebrikizumab provides clinically meaningful improvements in atopic dermatitis in patients previously treated with dupilumab. |
|---|---|
| Authors: | Gold, Linda Stein, Gutermuth, Jan, Adam, David N, Flohr, Carsten, Weidinger, Stephan, Atwater, Amber Reck, Pierce, Evangeline, Yang, Fan Emily, Chen, Sherry, Pau-Charles, Ignasi, Beck, Lisa A |
| Source: | The British journal of dermatology 2023 Supplement; Vol. 188. |
| Journal Info: | Publisher: Oxford University Press / USA ISSN: 0007-0963 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2133 |
|---|---|
| DOI: | 10.1093/bjd/ljad162.010 |
